KOLKATA, India, Sept. 25, 2025 /PRNewswire/ -- In a major milestone for cancer care in Eastern India, doctors at Apollo…
TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) today announced that its subsidiary, MEDIROM…
MUTTENZ, Switzerland, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company developing OPT101 as an innovative…
new york , Sept. 14, 2025 (GLOBE NEWSWIRE) -- New York City, NY, September 14, 2025, TestoPrime introduced an effective…
The strategic association will enable the Indian defence HVAC&R leader to provide advanced oil-free chillers to meet the demand for…
K2 Think delivers performance on par with the most advanced reasoning models at a fraction of the size ABU DHABI,…
HSINCHU, Sept. 9, 2025 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane),…
Brand essence, 'on it,' reflects Genpact's strength to transform at scale NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Genpact (NYSE:…
New data demonstrate amivantamab combination significantly reduces common EGFR and MET resistance mutations seen with EGFR TKIs1 BEERSE, BELGIUM ,…
This press release is not intended for UK and US media. HERNEXEOS® (zongertinib tablets) has been approved based on an objective…